InMode (INMD) to Announce Earnings on Thursday

InMode (NASDAQ:INMDGet Free Report) is expected to issue its Q2 2026 results before the market opens on Thursday, July 23rd. Analysts expect InMode to announce earnings of $0.3327 per share and revenue of $93.0410 million for the quarter. Parties may review the information on the company’s upcoming Q2 2026 earning results page for the latest details on the call scheduled for Wednesday, August 5, 2026 at 9:30 AM ET.

InMode (NASDAQ:INMDGet Free Report) last announced its earnings results on Wednesday, May 6th. The healthcare company reported $0.25 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.30 by ($0.05). InMode had a net margin of 23.27% and a return on equity of 13.47%. The company had revenue of $82.02 million for the quarter, compared to analysts’ expectations of $79.84 million. During the same period in the previous year, the firm earned $0.31 EPS. The firm’s quarterly revenue was up 5.3% on a year-over-year basis.

InMode Stock Down 0.7%

InMode stock opened at $15.36 on Tuesday. The firm has a 50 day moving average price of $14.15 and a 200-day moving average price of $14.19. InMode has a twelve month low of $12.72 and a twelve month high of $16.74. The company has a market capitalization of $882.89 million, a P/E ratio of 11.29 and a beta of 1.91.

Analyst Upgrades and Downgrades

INMD has been the subject of several research reports. Barclays set a $19.00 price objective on InMode and gave the company an “overweight” rating in a report on Thursday, May 7th. Robert W. Baird lowered their target price on InMode from $17.00 to $14.00 and set a “neutral” rating on the stock in a research note on Thursday, May 7th. One equities research analyst has rated the stock with a Buy rating, six have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Hold” and an average price target of $16.00.

Get Our Latest Report on InMode

Institutional Investors Weigh In On InMode

A number of hedge funds and other institutional investors have recently bought and sold shares of INMD. Quadrant Capital Group LLC grew its position in shares of InMode by 127.8% in the fourth quarter. Quadrant Capital Group LLC now owns 1,945 shares of the healthcare company’s stock valued at $29,000 after purchasing an additional 1,091 shares in the last quarter. Advisory Services Network LLC purchased a new stake in shares of InMode in the third quarter worth about $37,000. Deutsche Bank AG lifted its holdings in shares of InMode by 35.9% in the fourth quarter. Deutsche Bank AG now owns 3,927 shares of the healthcare company’s stock worth $58,000 after buying an additional 1,037 shares in the last quarter. Parallel Advisors LLC boosted its position in shares of InMode by 113.3% in the fourth quarter. Parallel Advisors LLC now owns 4,318 shares of the healthcare company’s stock valued at $63,000 after acquiring an additional 2,294 shares during the period. Finally, Brooklyn Investment Group bought a new position in shares of InMode in the fourth quarter valued at approximately $154,000. Institutional investors own 68.04% of the company’s stock.

InMode Company Profile

(Get Free Report)

InMode Ltd. (NASDAQ:INMD) is a medical technology company headquartered in Israel that develops, manufactures and markets devices for aesthetic and medical treatments. The company specializes in energy-based technologies, primarily radiofrequency platforms, designed to deliver minimally-invasive and non-invasive procedures.

InMode’s product portfolio encompasses a range of modular systems targeting body contouring, facial rejuvenation, skin tightening and other cosmetic applications. Key offerings include devices built on proprietary radiofrequency and radiofrequency-assisted lipolysis, enabling physicians to perform treatments such as tissue coagulation, skin resurfacing and subdermal volumizing with reduced downtime.

The company distributes its technologies through direct sales operations and distribution partners, serving medical professionals across multiple geographies including North America, Europe, Asia Pacific and Latin America.

Read More

Earnings History for InMode (NASDAQ:INMD)

Receive News & Ratings for InMode Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InMode and related companies with MarketBeat.com's FREE daily email newsletter.